These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment results for 149 medulloblastoma patients from one institution. Khafaga Y, Kandil AE, Jamshed A, Hassounah M, DeVol E, Gray AJ. Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):501-6. PubMed ID: 8655373 [Abstract] [Full Text] [Related]
8. Medulloblastoma: time-dose relationship based on a 30-year review. del Charco JO, Bolek TW, McCollough WM, Maria BL, Kedar A, Braylan RC, Mickle JP, Buatti JM, Mendenhall NP, Marcus RB. Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):147-54. PubMed ID: 9747832 [Abstract] [Full Text] [Related]
9. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients. Sure U, Bertalanffy H, Isenmann S, Brandner S, Berghorn WJ, Seeger W, Aguzzi A. Acta Neurochir (Wien); 1995 Aug 01; 136(3-4):117-26. PubMed ID: 8748840 [Abstract] [Full Text] [Related]
10. Prognostic factors for medulloblastoma. Jenkin D, Shabanah MA, Shail EA, Gray A, Hassounah M, Khafaga Y, Kofide A, Mustafa M, Schultz H. Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):573-84. PubMed ID: 10837938 [Abstract] [Full Text] [Related]
11. Low-dose craniospinal radiation therapy for medulloblastoma. Halberg FE, Wara WM, Fippin LF, Edwards MS, Levin VA, Davis RL, Prados MB, Wilson CB. Int J Radiat Oncol Biol Phys; 1991 Apr 01; 20(4):651-4. PubMed ID: 2004939 [Abstract] [Full Text] [Related]
12. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS. Eur J Cancer; 2005 Mar 01; 41(5):727-34. PubMed ID: 15763649 [Abstract] [Full Text] [Related]